Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2000 Feb;68(2):170–177. doi: 10.1136/jnnp.68.2.170

Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study

M Rovaris 1, B Viti 1, G Ciboddo 1, S Gerevini 1, R Capra 1, G Iannucci 1, G Comi 1, M Filippi 1
PMCID: PMC1736780  PMID: 10644783

Abstract

OBJECTIVE—Magnetisation transfer imaging (MTI) provides information about brain damage with increased pathological specificity over conventional MRI and detects subtle abnormalities in the normal appearing brain tissue, which go undetected with conventional scanning. Brain MRI and MTI findings were compared in patients with multiple sclerosis (MS) and systemic immune mediated diseases (SIDs) affecting the CNS to investigate their roles in understanding the nature of brain damage in these diseases.
METHODS—Brain dual echo, T1 weighted and MTI scans were obtained in patients affected by systemic lupus erithematosus (SLE) with (NSLE, n=9) and without clinical CNS involvement (n=15), Behçet's disease (BD) (n=5), Wegener's granulomatosis (WG) (n=9), and antiphospholipid antibody syndrome (APLAS) (n=6). Ten patients with clinically definite MS and 15 healthy controls also underwent the same scanning protocol. Brain MRI and MT ratio (MTR) images of the same subject were coregistered and postprocessed to obtain MTR histograms of the whole brain and of the NABT.
RESULTS—Brain hyperintense lesions were found in all patients with MS and with NSLE and in 5/15 patients with SLE, 5/9 with WG, 1/5 with BD, and 3/6 with APLAS. The lesion burden in the brain was significantly higher in patients with MS compared with all the other disease groups. All MTR histogram parameters were significantly different among patient subgroups. Patients with MS had significantly lower average MTR than all except patients with NSLE and significantly lower peak height and location than patients with SLE. patients with NSLE had significantly lower average MTR than patients with SLE.
CONCLUSIONS—Microscopic brain tissue damage is relevant in patients with MS, but, apart from patients with NSLE, it seems to be absent in systemic immune mediated diseases, even in the presence of macroscopic MRI lesions or clinical evidence of CNS involvement.



Full Text

The Full Text of this article is available as a PDF (247.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barkhof F., Filippi M., van Waesberghe J. H., Molyneux P., Rovaris M., Lycklama à Nijeholt G., Tubridy N., Miller D. H., Yousry T. A., Radue E. W. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology. 1997 Dec;49(6):1682–1688. doi: 10.1212/wnl.49.6.1682. [DOI] [PubMed] [Google Scholar]
  2. Bell C. L., Partington C., Robbins M., Graziano F., Turski P., Kornguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum. 1991 Apr;34(4):432–441. doi: 10.1002/art.1780340408. [DOI] [PubMed] [Google Scholar]
  3. Calabrese L. H., Duna G. F., Lie J. T. Vasculitis in the central nervous system. Arthritis Rheum. 1997 Jul;40(7):1189–1201. doi: 10.1002/1529-0131(199707)40:7<1189::AID-ART2>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  4. Chinn R. J., Wilkinson I. D., Hall-Craggs M. A., Paley M. N., Shortall E., Carter S., Kendall B. E., Isenberg D. A., Newman S. P., Harrison M. J. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum. 1997 Jan;40(1):36–46. doi: 10.1002/art.1780400107. [DOI] [PubMed] [Google Scholar]
  5. Coban O., Bahar S., Akman-Demir G., Serdaroğlu P., Baykan-Kurt B., Tolun R., Yurdakul S., Yazici H. A controlled study of reliability and validity of MRI findings in neuro-Behçet's disease. Neuroradiology. 1996 May;38(4):312–316. doi: 10.1007/BF00596576. [DOI] [PubMed] [Google Scholar]
  6. Davie C. A., Feinstein A., Kartsounis L. D., Barker G. J., McHugh N. J., Walport M. J., Ron M. A., Moseley I. F., McDonald W. I., Miller D. H. Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system. J Neurol. 1995 Aug;242(8):522–528. doi: 10.1007/BF00867424. [DOI] [PubMed] [Google Scholar]
  7. Fieschi C., Rasura M., Anzini A., Beccia M. Central nervous system vasculitis. J Neurol Sci. 1998 Jan 8;153(2):159–171. doi: 10.1016/s0022-510x(97)00288-8. [DOI] [PubMed] [Google Scholar]
  8. Filippi M., Campi A., Dousset V., Baratti C., Martinelli V., Canal N., Scotti G., Comi G. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology. 1995 Mar;45(3 Pt 1):478–482. doi: 10.1212/wnl.45.3.478. [DOI] [PubMed] [Google Scholar]
  9. Filippi M., Iannucci G., Tortorella C., Minicucci L., Horsfield M. A., Colombo B., Sormani M. P., Comi G. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology. 1999 Feb;52(3):588–594. doi: 10.1212/wnl.52.3.588. [DOI] [PubMed] [Google Scholar]
  10. Gerber S., Biondi A., Dormont D., Wechsler B., Marsault C. Long-term MR follow-up of cerebral lesions in neuro-Behçet's disease. Neuroradiology. 1996 Nov;38(8):761–768. doi: 10.1007/s002340050343. [DOI] [PubMed] [Google Scholar]
  11. Gumà A., Aguilera C., Acebes J., Arruga J., Pons L. Meningeal involvement in Behçet's disease: MRI. Neuroradiology. 1998 Aug;40(8):512–515. doi: 10.1007/s002340050635. [DOI] [PubMed] [Google Scholar]
  12. Hachulla E., Michon-Pasturel U., Leys D., Pruvo J. P., Queyrel V., Masy E., Arvieux J., Caron C., Brevet-Coupé F., Hatron P. Y. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus. 1998;7(2):124–131. doi: 10.1191/096120398678919868. [DOI] [PubMed] [Google Scholar]
  13. How A., Dent P. B., Liao S. K., Denburg J. A. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1985 Jul;28(7):789–795. doi: 10.1002/art.1780280710. [DOI] [PubMed] [Google Scholar]
  14. IJdo J. W., Conti-Kelly A. M., Greco P., Abedi M., Amos M., Provenzale J. M., Greco T. P. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus. 1999;8(2):109–115. doi: 10.1191/096120399678847461. [DOI] [PubMed] [Google Scholar]
  15. Karussis D., Leker R. R., Ashkenazi A., Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol. 1998 Oct;44(4):629–634. doi: 10.1002/ana.410440408. [DOI] [PubMed] [Google Scholar]
  16. Kermode A. G., Thompson A. J., Tofts P., MacManus D. G., Kendall B. E., Kingsley D. P., Moseley I. F., Rudge P., McDonald W. I. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain. 1990 Oct;113(Pt 5):1477–1489. doi: 10.1093/brain/113.5.1477. [DOI] [PubMed] [Google Scholar]
  17. Khamashta M. A., Hughes G. R. Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol. 1995 Sep;7(5):389–394. doi: 10.1097/00002281-199509000-00005. [DOI] [PubMed] [Google Scholar]
  18. Kozora E., West S. G., Kotzin B. L., Julian L., Porter S., Bigler E. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1998 Jan;41(1):41–47. doi: 10.1002/1529-0131(199801)41:1<41::AID-ART6>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  19. Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444–1452. doi: 10.1212/wnl.33.11.1444. [DOI] [PubMed] [Google Scholar]
  20. Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., Calabrese L. H., Fries J. F., Lie J. T., Lightfoot R. W., Jr The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990 Aug;33(8):1101–1107. doi: 10.1002/art.1780330807. [DOI] [PubMed] [Google Scholar]
  21. Liem M. D., Gzesh D. J., Flanders A. E. MRI and angiographic diagnosis of lupus cerebral vasculitis. Neuroradiology. 1996 Feb;38(2):134–136. doi: 10.1007/BF00604798. [DOI] [PubMed] [Google Scholar]
  22. Losseff N. A., Wang L., Lai H. M., Yoo D. S., Gawne-Cain M. L., McDonald W. I., Miller D. H., Thompson A. J. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain. 1996 Dec;119(Pt 6):2009–2019. doi: 10.1093/brain/119.6.2009. [DOI] [PubMed] [Google Scholar]
  23. Lublin F. D., Reingold S. C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 Apr;46(4):907–911. doi: 10.1212/wnl.46.4.907. [DOI] [PubMed] [Google Scholar]
  24. McGowan J. C., Filippi M., Campi A., Grossman R. I. Magnetisation transfer imaging: theory and application to multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998 May;64 (Suppl 1):S66–S69. [PubMed] [Google Scholar]
  25. Miller D. H., Barkhof F., Berry I., Kappos L., Scotti G., Thompson A. J. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):683–688. doi: 10.1136/jnnp.54.8.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Miller D. H., Barkhof F., Nauta J. J. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain. 1993 Oct;116(Pt 5):1077–1094. doi: 10.1093/brain/116.5.1077. [DOI] [PubMed] [Google Scholar]
  27. Miller D. H., Grossman R. I., Reingold S. C., McFarland H. F. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain. 1998 Jan;121(Pt 1):3–24. doi: 10.1093/brain/121.1.3. [DOI] [PubMed] [Google Scholar]
  28. Miller D. H., Ormerod I. E., Gibson A., du Boulay E. P., Rudge P., McDonald W. I. MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology. 1987;29(3):226–231. doi: 10.1007/BF00451758. [DOI] [PubMed] [Google Scholar]
  29. Nadeau S. E. Diagnostic approach to central and peripheral nervous system vasculitis. Neurol Clin. 1997 Nov;15(4):759–777. doi: 10.1016/s0733-8619(05)70346-7. [DOI] [PubMed] [Google Scholar]
  30. Phillips M. D., Grossman R. I., Miki Y., Wei L., Kolson D. L., van Buchem M. A., Polansky M., McGowan J. C., Udupa J. K. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol. 1998 Jun-Jul;19(6):1055–1060. [PMC free article] [PubMed] [Google Scholar]
  31. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  32. Provenzale J. M., Allen N. B. Wegener granulomatosis: CT and MR findings. AJNR Am J Neuroradiol. 1996 Apr;17(4):785–792. [PMC free article] [PubMed] [Google Scholar]
  33. Robb R. A., Hanson D. P., Karwoski R. A., Larson A. G., Workman E. L., Stacy M. C. Analyze: a comprehensive, operator-interactive software package for multidimensional medical image display and analysis. Comput Med Imaging Graph. 1989 Nov-Dec;13(6):433–454. doi: 10.1016/0895-6111(89)90285-1. [DOI] [PubMed] [Google Scholar]
  34. Rovaris M., Filippi M., Calori G., Rodegher M., Campi A., Colombo B., Comi G. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol. 1997 Apr;244(4):266–270. doi: 10.1007/s004150050083. [DOI] [PubMed] [Google Scholar]
  35. Rovaris M., Filippi M., Falautano M., Minicucci L., Rocca M. A., Martinelli V., Comi G. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology. 1998 Jun;50(6):1601–1608. doi: 10.1212/wnl.50.6.1601. [DOI] [PubMed] [Google Scholar]
  36. Sailer M., Burchert W., Ehrenheim C., Smid H. G., Haas J., Wildhagen K., Wurster U., Deicher H. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus. J Neurol. 1997 Mar;244(3):186–193. doi: 10.1007/s004150050071. [DOI] [PubMed] [Google Scholar]
  37. Shapiro S. S. The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med. 1996;47:533–553. doi: 10.1146/annurev.med.47.1.533. [DOI] [PubMed] [Google Scholar]
  38. Sibbitt W. L., Jr, Haseler L. J., Griffey R. R., Friedman S. D., Brooks W. M. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol. 1997 Aug;18(7):1271–1277. [PMC free article] [PubMed] [Google Scholar]
  39. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  40. Triulzi F., Scotti G. Differential diagnosis of multiple sclerosis: contribution of magnetic resonance techniques. J Neurol Neurosurg Psychiatry. 1998 May;64 (Suppl 1):S6–14. [PubMed] [Google Scholar]
  41. Truyen L., van Waesberghe J. H., van Walderveen M. A., van Oosten B. W., Polman C. H., Hommes O. R., Adèr H. J., Barkhof F. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 1996 Dec;47(6):1469–1476. doi: 10.1212/wnl.47.6.1469. [DOI] [PubMed] [Google Scholar]
  42. Uhlenbrock D., Sehlen S. The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE). Neuroradiology. 1989;31(3):203–212. doi: 10.1007/BF00344344. [DOI] [PubMed] [Google Scholar]
  43. Weingarten K., Filippi C., Barbut D., Zimmerman R. D. The neuroimaging features of the cardiolipin antibody syndrome. Clin Imaging. 1997 Jan-Feb;21(1):6–12. doi: 10.1016/0899-7071(95)00044-5. [DOI] [PubMed] [Google Scholar]
  44. West S. G., Emlen W., Wener M. H., Kotzin B. L. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med. 1995 Aug;99(2):153–163. doi: 10.1016/s0002-9343(99)80135-1. [DOI] [PubMed] [Google Scholar]
  45. van Buchem M. A., Grossman R. I., Armstrong C., Polansky M., Miki Y., Heyning F. H., Boncoeur-Martel M. P., Wei L., Udupa J. K., Grossman M. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology. 1998 Jun;50(6):1609–1617. doi: 10.1212/wnl.50.6.1609. [DOI] [PubMed] [Google Scholar]
  46. van Buchem M. A., McGowan J. C., Kolson D. L., Polansky M., Grossman R. I. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med. 1996 Oct;36(4):632–636. doi: 10.1002/mrm.1910360420. [DOI] [PubMed] [Google Scholar]
  47. van Waesberghe J. H., van Walderveen M. A., Castelijns J. A., Scheltens P., Lycklama à Nijeholt G. J., Polman C. H., Barkhof F. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol. 1998 Apr;19(4):675–683. [PMC free article] [PubMed] [Google Scholar]
  48. van Walderveen M. A., Kamphorst W., Scheltens P., van Waesberghe J. H., Ravid R., Valk J., Polman C. H., Barkhof F. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998 May;50(5):1282–1288. doi: 10.1212/wnl.50.5.1282. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES